As part of the process of engaging with the industrial science community, Diamond established the Diamond Industrial Science Committee (DISCo).
The Terms of Reference of DISCo are to:
- advise the CEO and Directors of Diamond on opportunities for industry to be engaged in research at Diamond, and the best means for promoting such opportunities;
- identify industrial research priorities that will help shape the operational strategy of DLS- including the best way to exploit the current suite of beamlines and to develop the case for investment in future beamlines;
- develop best practice for industrial engagement with Diamond, including the nature of research collaboration agreements, the handling of IP and the dissemination of research outcomes;
- carry out other tasks as agreed with the CEO and the Directors of DLS.
The current membership of DISCo is:
Dr Malcolm Skingle, GlaxoSmithKline (Chair)
Dr Peter Ash, Johnson Matthey
Dr John Barker, Evotec
Prof. David Brown, Cangenix Ltd
Dr Rob Cooke, Heptares Therapeutics
Dr Jonathan Hyde, NNL
Dr Matthew Johnson, GlaxoSmithKline
Dr Anne Kavanagh, AstraZeneca
Dr Ken Lewtas, Infineum
Prof. Dave Rugg, Rolls-Royce
Dr Ian Tucker, Unilever
along with Shareholder & Stakeholder representatives.